RxDoctor Payments Data

Abigail Connerly, APRN

Nurse Practitioner · Little Rock, ARNPI 1104476720

Payments from drug & device makers

$1,491in general payments, 2019–2025

Across 32 payments — averaging $46.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$38
  • Siemens Medical Solutions USA, Inc.$25
  • Johnson & Johnson$15
  • Boston Scientific$12

What the payments were for

  • Food & beverage$1,491100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,491 in reported general payments places this provider in the 75th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas

Medicare billing

Part B allowed, 2024
$147,208
Medicare patients
875
Services billed
4,823

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban299$254,901
XareltoRivaroxaban34$28,766
EntrestoSacubitril/Valsartan33$28,412
Dofetilide151$27,166
Repatha SureclickEvolocumab11$5,899
Potassium Chloride346$5,604
Flecainide Acetate92$3,131
Bumetanide76$2,803
SotalolSotalol Hcl130$1,889
Losartan Potassium231$1,528
Mexiletine Hcl11$1,006
Carvedilol158$986
Metoprolol Tartrate151$958
Furosemide217$885
Metoprolol Succinate77$767

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$15$28,76634 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 697 nurse practitioner providers in Arkansas.

Other nurse practitioner in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →